JPRN-jRCT2080221429未知3 期
A Phase 3, Multicenter Randomized, Double-Blind, Placebo Controlled, Trial of AMG 479 or Placebo in Combination with Gemcitabine as First-line Therapy for Metastatic Adenocarcinoma of the Pancreas
试验速览
- 阶段
- 3 期
- 入组人数
- 825
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- >= 18age old 至 ot applicable（—）
- 性别
- All
入选标准
- •Major inclusion criteria include the following:
- •1) Untreated metastatic adenocarcinoma of the pancreas
- •2) Adequate hematologic, renal and liver function
- •3) Eastern Cooperative Oncology Group (ECOG) performance status : 0 or 1
排除标准
- •Major exclusion criteria include the following:
- •1) Prior chemotherapy or radiotherapy for pancreatic cancer
- •2) Central nervous system metastases
- •3) External biliary drain
研究者
相似试验
进行中（未招募）
1 期
Research study of Rolapitant versus Placebo for the prevention of nausea and vomiting related to chemotherapy that has a high likelihood of inducing nausea and vomiting.Chemotherapy-Induced Nausea and Vomiting (CINV) in Subjects Receiving Highly Emetogenic Chemotherapy (HEC)MedDRA version: 14.1 Level: PT Classification code 10054133 Term: Prophylaxis of nausea and vomiting System Organ Class: 10042613 - Surgical and medical proceduresMedDRA version: 14.1 Level: LLT Classification code 10049091 Term: Chemotherapy antiemetic prophylaxis System Organ Class: 10042613 - Surgical and medical proceduresEUCTR2010-022742-25-ESTesaro, Inc.526
进行中（未招募）
不适用
Research study of Rolapitant versus Placebo for the prevention of nausea and vomiting related to chemotherapy that has a high likelihood of inducing nausea and vomiting.Chemotherapy-Induced Nausea and Vomiting (CINV) in Subjects Receiving Highly Emetogenic Chemotherapy (HEC)MedDRA version: 16.0Level: PTClassification code 10054133Term: Prophylaxis of nausea and vomitingSystem Organ Class: 10042613 - Surgical and medical proceduresMedDRA version: 16.0Level: LLTClassification code 10049091Term: Chemotherapy antiemetic prophylaxisSystem Organ Class: 10042613 - Surgical and medical proceduresEUCTR2010-022742-25-PTTesaro, Inc.530
进行中（未招募）
不适用
AMG 102 Plus ECX for Unresectable Locally Advanced or Metastatic Gastricor Esophagogastric Junction CancerEUCTR2011-004923-11-ITAMGEN INC.450
招募中
1 期
A Clinical Trial to Test the Safety, Effect, and Activity of Rilzabrutinib (PRN1008) in Adult and Adolescent Patients with Persistent or Chronic Immune Thrombocytopenia (ITP).CTIS2023-509401-71-00Principia Biopharma Inc.224
进行中（未招募）
不适用
A Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Subcutaneous LY2127399 in Patients with Systemic Lupus Erythematosus (SLE) (ILLUMINATE-2) - ILLUMINATE-2Systemic Lupus Erythematosus (SLE)MedDRA version: 14.1Level: LLTClassification code 10025139Term: Lupus erythematosus systemicSystem Organ Class: 100000004859EUCTR2010-022100-42-HUEli Lilly and Company1,140